why choose us

First received: November 29, 2022

Clinical Trial: Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gastrointestinal Cancers

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Single Arm, Open Label, Non-Randomized Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

Brief Summary: Prospective, multi-center, open label, non-randomized clinical trial to assess efficacy of [18F]FAPI-74 to detect FAP expressing cells in patients diagnosed with gastrointestinal cancers, including hepatocellular carcinoma, cholangiocarcinoma, gastric, pancreatic and colorectal cancer.The [18F]FAPI-74 PET scan will be acquired in patients with proven GI cancers after initial staging using institutional standard methods.The PET scan results will be compared to FAP immunohistochemistry (as the primary objective) and…

Read more